Influenza A H1N1 2009 vaccine in juvenile dermatomyositis reduced immunogenicity in patients under immunosuppressive therapy
Paediatric rheumatology
In uenza A H1N1/2009 vaccine in juvenile dermatomyositis:
reduced immunogenicity in patients under
immunosuppressive therapy
V.R. Guissa1, R.M.R. Pereira2, A.M.E Sallum1, N.E. Aikawa1,2, L.M.A. Campos1,
C.A. Silva1,2, E. Bonfá2
1
Paediatric Rheumatology Unit and 2Division of Rheumatology, Faculdade de Medicina da
Universidade de São Paulo, São Paulo, Brazil.
Objectives
The aim of the present paper is to assess the in uence of demographic, muscle enzymes, JDM scores and treatment on non-adjuvanted in uenza A H1N1/2009 vaccine immunogenicity in juvenile dermatomyositis (JDM) patients.Thirty JDM patients and 81 healthy age-matched controls were vaccinated. All participants were evaluated pre- and 21 days post-vaccination and serology for anti-H1N1 was performed by haemagglutination inhibition assay. Muscle enzymes,
JDM scores and treatment were evaluated before and after vaccination. Adverse events were reported.After immunisation, seroconversion rates were signi cantly lower in JDM patients compared to age-matched controls (86.7 vs. 97.5%, p=0.044), whereas seroprotection (p=0.121), geometric mean titres (GMT) (p=0.992) and factor increase (FI) in GMT (p=0.827) were similar in both groups. Clinical and laboratorial evaluations revealed that JDM scores and muscle enzymes remained stable throughout the study (p>0.05). A higher frequency of chronic course was observed in non-seroconverted compared to seroconverted (100% vs. 27%, p=0.012). Regarding treatment, a lower rate of seroconversion was observed in patients under prednisone>20mg/day (50% vs. 4%, p=0.039), and in those treated with a combination of prednisone, methotrexate and cyclosporine (50% vs. 4%, p=0.039). Local and systemic vaccine adverse events were mild
and similar in patients and controls (p>0.05). This study identi ed that chronic course and immunosuppressive therapy are the major factors hampering seroconversion in JDM, suggesting that a speci c protocol may be required for this subgroup of patients. In spite of that, a single dose of non-adjuvanted in uenza A/H1N1 2009 vaccine was generally seroprotective in this disease with no evident deleterious
effect in disease itself (ClinicalTrials.gov, no. NCT01151644).
vaccine, immunogenicity, in uenza A H1N1/2009, children, juvenile dermatomyositis
Influenza (the flu)_英语学习_外语学习_教育专区。流感预防Influenza (the flu) By Salwa Hassan Teama Ain Shams University Difference Between Cold or FLU ...
流感病毒与流感疫苗 - Influenza and Influenza Vaccines_生物学_自然科学_专业资料。流感病毒与流感疫苗 - Influenza and Influenza Vaccines...
Influenza (Flu) What Everyone Should Know About Flu and the Flu Vaccine What is the flu? The flu is a contagious respiratory illness caused by ...
Influenza Miley ClassB Influenza, commonly referred to as the flu, is an infectious disease caused by RNA viruses of the family Orthomyxoviridae (the ...
Influenza (flu): ? is a highly infectious viral disease caused by various types of influenza viral strains ? Seasonal Influenza In Hong Kong, the ...
42页 免费 Influenza 32页 10财富值搜你所想,读你所爱 拒绝盗版,营造绿色文库 如要投诉违规内容,请到百度文库投诉中心;如要提出功能问题或意见建议,请点击...
www.themegallery.com Spring - prone diseases Epidemic cerebrospinal meningitis、 、 influenza , mumps and other respiratory diseases流脑、流感、流腮等呼吸道...
Summer 2008 Workshop in Biology and Multimedia for High School Teachers INFLUENZA VIRUS: A Model for Learning About Disease Laurie St.Pierre Sandwich High...
流行性感冒病毒 influenza virus 流行性感冒病毒(influenza virus)简称流感 病毒。按病毒核蛋白(nucleocapside protein,NP) 和基质蛋白(matrix protein, M)分成甲(A)...
流行性感冒 influenza 定义:流行性感冒简称流感,是 由流行性感冒病毒引起的急性呼 吸道传染病。 特征:病毒极易变异; 传染性强; 全身症状重; 呼吸道症状轻。 ...
热门文档